Definition:Disability-morbidity risk sub-module
🏥 Disability-morbidity risk sub-module is a component of the solvency capital requirement calculation under the Solvency II framework that quantifies the capital an insurer must hold against adverse changes in the level, trend, or volatility of disability and morbidity rates affecting its life and health insurance obligations. It captures the risk that more policyholders than expected become disabled, fall ill, or experience deterioration in their health status, leading to higher claim payments or longer benefit periods than actuarial assumptions anticipated. Within the standard formula, this sub-module sits under the life underwriting risk module, though analogous morbidity risk charges also appear in the health underwriting risk module depending on the nature of the business written.
⚙️ Calculation under the standard formula involves applying prescribed stress scenarios to the insurer's best estimate liabilities. Typically, the sub-module tests two directions of risk: an increase in disability and morbidity inception rates (the probability that a healthy policyholder becomes disabled or ill) and a decrease in recovery rates (the probability that a disabled policyholder returns to health). The insurer recalculates its technical provisions under each stressed scenario and measures the resulting change in net asset value. These individual shocks are then combined, often using prescribed correlation assumptions, to produce the sub-module's capital charge. Firms using an internal model have latitude to calibrate these stresses to their own portfolio experience, but must still demonstrate to their supervisor that the model captures disability-morbidity risk at a 99.5% VaR confidence level over a one-year horizon. The precise calibration of the standard formula stresses is set out in the delegated acts supplementing Solvency II.
💡 Accurate quantification of disability-morbidity risk is essential for insurers writing income protection, critical illness, long-term care, or group disability products — lines of business where claims can persist for years and small shifts in morbidity trends compound into significant reserve movements. Underestimating this risk erodes an insurer's solvency ratio and can trigger supervisory intervention, while overestimating it ties up capital that could otherwise support growth or be returned to shareholders. Beyond Europe, similar concepts exist in other risk-based capital regimes: the NAIC RBC framework in the United States incorporates morbidity risk through its C-2 factor, and frameworks such as HKRBC, C-ROSS, and Singapore's RBC 2 each address disability and morbidity exposures in their own calibrations. Regardless of jurisdiction, the underlying challenge is the same: projecting the future health trajectory of a policyholder population in the face of evolving medical, demographic, and socioeconomic trends.
Related concepts: